Skip to main content

Table 8 Recommendation summary - blood pressure management

From: Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines

  CEBAM ACP HAS KDIGO KHA-CARI BCMA UMHS VA-DoD NICE
2012 2013 2013 2013 2013 2014 2014 2014 2015
Blood pressure management
 BP monitoring intervals          
 individualized BP targets        
 BP target < 140/90  
 BP target in diabetics < 140/90        GP   
  < 140/80          
  < 130/80        
 BP target in ≥ microalbuminuria < 140/90         
  < 130/80      i  
 medication renin-angiotensin system antagonist       i ➢    i
  ACEI i i   i i i i  
  ARB   i   i i i i  
  combination of ACEI + ARB      
  combination of ACEI/ARB + direct renin inhibitor       
  diuretics      i i    
  β-blocker      i i    
  calcium channel blocker      i i    
  side effects         
  1. ▪ recommendation, − negative recommendation, i: when indicated, ➢ recommendations in KDIGO BP guideline, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, BP blood pressure, DM diabetes mellitus, ev insufficient evidence for recommendation, GP: identical blood pressure targets as general population, n.a.: not applicable
  2. American College of Physicians (ACP), Belgisch Centrum voor Evidence Based Medicine (CEBAM), British Columbia Medical Association (BCMA), Department of Veteran’s Affairs (VA-DoD), Haute Autorité de Santé (HAS), Kidney Disease Improving Global Outcomes (KDIGO), Kidney Health Australia - Caring for Australasiansians with Renal Impairment (KHA-CARI), National Institute of Health and Care Excellence (NICE), University of Michigan Health System (UMHS)